Beauty of Joseon Revive Eye Serum (Ginseng + Retinal): US Market, Ingredient & Price Analysis

1. Product Information

Everything in this section is transcribed from the live US listing at capture time. Prices are native USD for a New York delivery address; no currency conversion is applied anywhere in this report.

1.1 What the product is

Beauty of Joseon's Revive Eye Serum is a 30 ml (1.01 fl oz) retinal eye treatment built on two headline materials: Panax ginseng root water (declared at 10% in the ingredient database entry) and retinal liposomes. The brand frames it as an anti-wrinkle, firming and hydrating step for the delicate eye area, with a lightweight serum-cream texture that absorbs quickly, layers under makeup, and is marketed as gentle enough for all skin types. It ranks #458 in Beauty & Personal Care and #2 in Eye Treatment Serums at capture time, sold by the brand's official store and shipped by Amazon.

Usage is classic eye-care: a small amount patted around the eye orbit morning and night. The retinal is delivered in encapsulated liposome form, which the brand presents as the reason a prescription-adjacent retinoid can sit in a daily-use product. The maker of record is GREEN COS Co., Ltd., the brand's Korean manufacturer, and the model number JSMS01-I ties the listing to the single 30 ml size.

1.2 Listing specification

1.3 What the brand says

1. 1Visibly Firms and Targets Wrinkles: Retinal liposomes and ginseng water improve the look of skin elasticity and help soften the look of fine lines and wrinkles.
2. 2Non-Sticky and Nourishing: Made with a lightweight serum texture that absorbs quickly without stickiness.
3. 3Helps Hydrate + Visibly Smooth: Our formula with ginseng root extract and retinal liposomes helps hydrate the delicate eye area while encouraging visibly smoother skin.
4. 4Smooth, Silky Feel: Unique serum texture glides on smooth with a refreshing, fast-absorbing silky finish that layers well with the rest of your daily skincare routine.
5. 5Gentle Eye Care for All Skin Types: Suitable for every eye care routine and anyone looking to help wake up tired under eyes.

1.4 Brand content and routine context

The A+ module is short and claim-led: three tiles labelled Clinically Tested, Retinal and Retinal Liposome, followed by a video block and a 'clean eye duo' cross-sell pairing this serum with a companion eye product. The tiles assert clinical testing without publishing the study, sample size or endpoint in the module text, and the retinal-liposome tile is the closest thing to a mechanism claim. No before/after imagery, percentage improvement figure or dermatologist attribution is exposed in the extractable content.

2. Product Rating

The listing reports an average of 4.4 / 5 across 21,954 global ratings. The distribution below is the share of ratings in each star bucket, as published by the marketplace.

A 4.4 average on more than 21,000 ratings is respectable but visibly softer than category leaders: 71% five-star against a 6% one-star share, roughly one full point of five-star share below a typical 4.6 product. The 6% one-star bucket implies on the order of 1,300 unhappy ratings — a meaningful minority for a product whose active is a retinoid, where irritation and 'no visible result' are the standard failure modes. Bucket counts are rounded from published shares, so expect a point of drift between captures.

3. Product Ingredients

This section merges two independent community ingredient databases into a single view. Every ingredient is classified by formulation role and by exposure level (comedogenic / irritancy / acne risk). Classifications are reference material, not a regulatory or dermatological verdict.

3.1 What's inside — claim matrix

Free-from and suitability claims as evaluated by the ingredient database. A NO result is a flag on one or more listed ingredients, not a statement that the product fails in use.

3.2 Ingredient composition by formulation role

3.3 Exposure level classification

Exposure level combines the comedogenic rating, the irritancy rating and the acne-risk rating; the highest value observed wins. 0 = no known risk, 1–2 = moderate, 3+ = elevated, "Unrated" = the source did not rate it.

3.4 Key ingredient groups and stated benefits

3.5 Flagged concerns

3.6 Merged ingredient table (36 ingredients)

Acne / Irritant / Safety columns come from the COSDNA channel (Acne and Irritant are low-is-safer; Safety is inverse, 1 = safest). Comedogenic / Irritancy come from the Skinsort channel. "not rated" means the source published no value — it is never read as zero.

3.7 Channel A ingredient table (36 ingredients)

3.8 Channel B ingredient table (36 ingredients)

The two channels agree on a well-built emulsion: water and 10% ginseng root extract lead, followed by glycerin, a pair of emollient esters, niacinamide, olive-derived emulsifiers, and a barrier-support tail of cholesterol, ceramide NP, sodium hyaluronate and tocopherol. Retinal sits at position 24 of 36 — present, encapsulated, and declared at 2% in the database entry, though INCI order means the emollient and humectant base outweighs it. The database flags cetearyl alcohol (comedogenic 2) as the sole pore-clog marker, rates the formula non-fungal-acne-safe with six flagged ingredients, and prints a wide 1–9 safety band on retinal itself — the reason the exposure chart shows an elevated bucket at all. Unlike the average eye cream, this one is vegan, fragrance-free and EU-allergen-free per the claim matrix.

4. What Shoppers Report

The marketplace publishes an aggregated sentiment summary and a per-theme breakdown built from review text. These are marketplace-derived aggregates; individual reviewer identities are never reproduced in this report.

The theme table is the most instructive part of this report. Texture (92% positive) and absorption (96%) are near-universal wins — users agree the product feels good. Everything downstream of the experience is contested: effectiveness splits at 53% positive across 838 mentions, skin irritation lands at 39% across 381 mentions, skin sensitivity also 39%, and puffiness is a coin flip at 54%. That pattern is textbook retinoid: a well-formulated vehicle whose active works for some users, does nothing for others, and genuinely irritates a minority.

Disclosed gap: the marketplace returned no inline review text for this ASIN during the capture window (no buyer-photo tiles rendered either), so no verbatim quotes are reproduced here. The sentiment analysis above is built entirely from the marketplace's own aggregate widgets.

5. Product Price

All-time US price history from a public Amazon price-tracking service (collected 2026-10-26). The grouped bar chart compares the lowest, highest, current and average price for each tracked price type; the second chart places the live listing price against its own historical band.

This is the deepest price record of the three products in this batch: the tracker has followed the ASIN since July 2022, so its all-time band covers four years. The third-party-new channel has ranged from $11.00 (August 2024) to $29.99 (February 2024) with a $15.66 average; the Amazon-sold channel bottomed at $11.90 and topped at $16.99 with a $16.10 average. The live listing's $12.92 is comfortably below every tracked average and only $1.92 above the four-year floor — a strong entry point. The tracker's last scan is 19 days old, so treat its 'current' $17.00 as stale; the live quote of $12.92 (list $17.00, -24%, or $11.63 on subscription) is the actionable figure.

6. Product Images

6.1 Listing imagery

6.2 Buyer photos

No images of this type were exposed by the listing at capture time.

7. Methodology, Confidence & Limitations

• All figures are a single snapshot taken on 2026-10-26; rank, price and rating move between captures.
• No reviewer name, handle, profile link or reviewer ID appears anywhere in this report; reviewer identities are withheld by design.
• Ingredient ratings are community reference values, not a regulatory or clinical judgement.
• Exposure levels use the highest published value across channels; unrated ingredients are counted as unrated, never as zero risk.
• Re-verify the live price and the current formula before any purchase or formulation decision.